Croda International PLC Unsponsored ADR (OTCMKTS:COIHY – Get Free Report) was the target of a large growth in short interest in July. As of July 15th, there was short interest totaling 862 shares, a growth of 1,467.3% from the June 30th total of 55 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average trading volume of 7,055 shares, the days-to-cover ratio is presently 0.1 days.
Croda International Stock Up 2.8%
Shares of OTCMKTS COIHY traded up $0.53 during trading hours on Friday, hitting $19.50. The company had a trading volume of 8,517 shares, compared to its average volume of 15,546. The firm’s 50 day moving average is $19.90 and its 200-day moving average is $19.53. Croda International has a 1-year low of $16.26 and a 1-year high of $22.29. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.21.
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on COIHY. Kepler Capital Markets raised shares of Croda International from a “reduce” rating to a “hold” rating in a research note on Tuesday, March 31st. Zacks Research raised Croda International from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. One research analyst has rated the stock with a Strong Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.
Croda International Company Profile
Croda International plc is a UK-based specialty chemicals company headquartered in East Yorkshire, England. Established in 1925, Croda has built a global reputation for developing and manufacturing high-performance ingredients derived primarily from natural oils and renewable resources. The company’s research-driven approach has enabled it to innovate across a wide range of sectors, delivering solutions that combine efficacy, sustainability and compliance with stringent regulatory standards.
Croda’s operations are organized around three core segments: Personal Care, Life Sciences and Performance Technologies.
Featured Stories
- Five stocks we like better than Croda International
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
